Proceeds from issuance of common stock relating to employee stock plans
Moderna Proceeds from issuance of common stock relating to employee stock plans increased by 18.8% to $19.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 533.3%, from $3.00M to $19.00M. Over 4 years (FY 2021 to FY 2025), Proceeds from issuance of common stock relating to employee stock plans shows a downward trend with a -27.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher proceeds generally correlate with higher employee participation in equity plans and can indicate positive sentiment regarding the company's long-term stock performance.
Detailed definition
Cash inflows resulting from the exercise of employee stock options or purchases through employee stock purchase plans. T...
Peer comparison
Standard for most publicly traded companies with equity-based compensation programs.
financing_proceeds_from_stock_plansHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $36.00M | $32.00M | $28.00M | $12.00M | $17.00M | $11.00M | $25.00M | $9.00M | $16.00M | $6.00M | $15.00M | $15.00M | $32.00M | $8.00M | $11.00M | $3.00M | $14.00M | $2.00M | $16.00M | $19.00M |
| QoQ Change | — | -11.1% | -12.5% | -57.1% | +41.7% | -35.3% | +127.3% | -64.0% | +77.8% | -62.5% | +150.0% | +0.0% | +113.3% | -75.0% | +37.5% | -72.7% | +366.7% | -85.7% | +700.0% | +18.8% |
| YoY Change | — | — | — | — | -52.8% | -65.6% | -10.7% | -25.0% | -5.9% | -45.5% | -40.0% | +66.7% | +100.0% | +33.3% | -26.7% | -80.0% | -56.3% | -75.0% | +45.5% | +533.3% |
Proceeds from issuance of common stock relating to employee stock plans at Other Companies
Frequently Asked Questions
- What is Moderna's proceeds from issuance of common stock relating to employee stock plans?
- Moderna (MRNA) reported proceeds from issuance of common stock relating to employee stock plans of $19.00M in Q1 2026.
- How has Moderna's proceeds from issuance of common stock relating to employee stock plans changed year-over-year?
- Moderna's proceeds from issuance of common stock relating to employee stock plans increased by 533.3% year-over-year, from $3.00M to $19.00M.
- What is the long-term trend for Moderna's proceeds from issuance of common stock relating to employee stock plans?
- Over 4 years (2021 to 2025), Moderna's proceeds from issuance of common stock relating to employee stock plans has grown at a -27.1% compound annual growth rate (CAGR), from $124.00M to $35.00M.
- What does proceeds from issuance of common stock relating to employee stock plans mean?
- Cash received from employees exercising stock options or buying company shares.